S

Seegene Inc
KOSDAQ:096530

Watchlist Manager
Seegene Inc
KOSDAQ:096530
Watchlist
Price: 23 800 KRW 1.49% Market Closed
Market Cap: 1.2T KRW
Have any thoughts about
Seegene Inc?
Write Note

Seegene Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Seegene Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Seegene Inc
KOSDAQ:096530
Total Liabilities & Equity
â‚©1.3T
CAGR 3-Years
0%
CAGR 5-Years
47%
CAGR 10-Years
25%
Celltrion Inc
KRX:068270
Total Liabilities & Equity
â‚©19.9T
CAGR 3-Years
53%
CAGR 5-Years
39%
CAGR 10-Years
24%
SK Bioscience Co Ltd
KRX:302440
Total Liabilities & Equity
â‚©1.9T
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Liabilities & Equity
â‚©943B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Liabilities & Equity
â‚©640.8B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Liabilities & Equity
â‚©299.4B
CAGR 3-Years
6%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

Seegene Inc
Glance View

Market Cap
1.2T KRW
Industry
Biotechnology

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
23 185.53 KRW
Overvaluation 3%
Intrinsic Value
Price
S

See Also

What is Seegene Inc's Total Liabilities & Equity?
Total Liabilities & Equity
1.3T KRW

Based on the financial report for Sep 30, 2024, Seegene Inc's Total Liabilities & Equity amounts to 1.3T KRW.

What is Seegene Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
25%

Over the last year, the Total Liabilities & Equity growth was 0%.

Back to Top